Features
Latest Features
Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes
Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.
Bipolar Disorder and the Cardiovascular System
Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.
Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.
PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.
ASPREE Trial: Aspirin Associated With Higher Mortality, Hemorrhage Risk in Older Adults
The use of aspirin in healthy elderly patients as a preventative strategy was associated with no prolongation of long-term disability-free survival compared with placebo.
Enrolling the Uninsured in Clinical Trials: Is it Ethical?
Until universal access to healthcare is ensured as a human right, researchers must keep important ethical concerns in mind when designing future clinical trials.
Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking
The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.
Assessing the Evidence of Aspirin for Primary Prevention in Diabetes
The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction
A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.
Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
Current research suggests patients with pulmonary arterial hypertension may benefit from iron and vitamin D supplementation.
Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin
To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.
Unraveling the Relationship Between COPD and Stroke
Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.
Managing Cardiovascular Risk in Rheumatoid Cachexia
Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.
Improving Risk Stratification, Diagnostic Accuracy in PAH With Cardiopulmonary Exercise Testing
Cardiopulmonary exercise testing can be an important diagnostic and prognostic tool in pulmonary arterial hypertension.
Should Physicians Treat Family and Friends? Three Experts Weigh In
Although all of the guidelines acknowledge that there are emergent situations in which providing care for a family member or friend is not only permissible but also essential, other situations are frowned upon.
Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
How Many Chances Are Too Many? Treating Recurrent Infective Endocarditis in IV Drug Users
How many second chances should a drug user get? As many as it takes for us — physicians, society, government, and the healthcare system — to get it right.
Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE
Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.
Improved Pulmonary Arterial Hypertension Risk Prediction Tools Needed
The use of a risk calculator aimed at achieving a low-risk profile in PAH trials is discussed.
The Cardiology Advisor Articles
- Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks
- Harvard: Fraudulent Data Found in Publications of Heart Researcher
- Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women
- No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
- Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD
- Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
- Long-Term Exposure to Elevated BP Associated With AS and AR
- Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
- Takotsubo Syndrome Associated With Substantial Morbidity, Mortality
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes
- Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials
- Psoriasis Associated With Clinical Signs of Accelerated Atherosclerosis
- Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
- The Striking Effects of Diversity in Health Care: Improving Patient Outcomes